US FDA gives clearance to AffaMed’s bispecific biologic to treat retinal vascular diseases EP News Bureau Feb 16, 2022 AffaMed will soon initiate a phase-I study in the US to investigate the safety, tolerability, pharmacokinetics and efficacy of…
